EN; FR; IT; Investor Dashboard. ADRS) Profil - hier finden Sie alle Informationen über GALAPAGOS NV (SPONS. 01.06.2022 - Mechelen, Belgium; 1 June 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. The number of employees at Galapagos NV at the end of 2019 amounted to 361 as compared to 261 at the end of 2018, excluding insourced personnel. Depreciation increased to €403.3 million in 2019, compared to €305.7 million in 2018, and related primarily to amortization of R&D expenses. Investors: Sofie Van Gijsel Head of Investor Relations +1 781 296 1143. +32 485 19 14 15 Email: ir@glpg.com. Yahoo. Investor Overview | Gilead Sciences We spoke to team leaders Michele Manto and Emma Chaffin, who told us the story from both a global and local perspective. It was the year that saw the commercial side of our business step into the spotlight. Biography. Investor relations calendar Galapagos NV - AnnualReports.com Rezolute, Inc. (RZLT) Elizabeth Goodwin-- Vice President, Investor Relations Thank you all for joining us today for the audio webcast of Galapagos' first quarter 2020 results. Company. Galapagos NV (GLPG) Q4 2020 Earnings Call Transcript - Fool In 2020, Galapagos brought its first medicine to patients in Europe. Investors For all your investor relations questions … Galapagos Consistent with AMG’s Corporate Strategy, the company will continue to retain a portion of future earnings to improve the strength of its balance sheet and finance the development and expansion of its business.